Description: The Smaller Insurance Company Section Buzz Groups at the Valuation Actuary Meetings and the SOA Annual Meetings have always generated great discussions, ideas, and opportunities to hear about topics that affect the actuarial work of small companies. Join us for the Smaller Insurance Company Section Buzz Group to discuss the issues affecting Smaller (and larger) Insurance Company actuaries during these emerging changes. Bring your thoughts, opinions, ideas, and participation to discuss our special concerns.

Description: This article provides an alternative method to the computation of the Reduction in Benefits Test under 7702A. Part 1 provided for reduction in death benefits. Part 2 provides for reduction in Qualified Additional Benefits.

Description: The session will discuss key areas of statutory reserving that contain some ambiguity or areas where there are simplifications being used in the industry. The content will be based on current practices used in the industry and possibly accompanied by an industry survey to be completed prior to the session. The focus will be heavily on CRVM, AG38, and PBR statutory frameworks and will include a Q&A portion for audience participation. Some potential topics will be reinsurance modeling, DBO3/ROP treatment, segmentation, deficiency reserves, system differences and multi-tiered designs

Description: Come discuss modeling costs and its governance, as well as introduce some platforms for more granular asset modeling.

Description: The primary purposes of the study are the following: 1. Compare recent industry experience for individual life waiver of premium (ILWOP) insurance products to the claim incidence and claim termination rates from the 1952 SOA Disability Table; 2. Analyze actual-to-expected (A/E) claim incidence and claim termination ratios across key segments such as gender, attained age, etc.; 3. Develop an illustrative experience basis for calculating policy and claim reserves based on the results from the A/E studies; and 4. Compare reserves calculated using experience assumptions to the reserves calculated using the 1952 SOA Disability Table for an illustrative cohort of ILWOP business.

Description: The Committee on Life Insurance Mortality and Underwriting Surveys of the Society of Actuaries Research Institute sent companies a survey in May of 2019 on mortality improvement practices. Note this survey was completed prior to the onset of COVID-19, so that issue was not addressed in this survey. The purpose of the survey was to examine mortality improvement practices with respect to life insurance and annuity pricing and financial projections in both the U.S. and Canada.

Description: Cayman is a rapidly growing reinsurance domicile with several notable transactions executed in the past few years. We expect this trend to persist as (re)insurers will continue to explore more effective ways to manage their business. In this session, you will gain: - An overview of how the Cayman (re)insurance market has developed over recent years - An introduction to the Cayman regulatory framework - Key considerations for reinsurance structuring and pricing. Join a discussion at the close of the session on the outlook for the Cayman market. You will leave this session with an understanding of the Cayman (re)insurance market, the regulatory framework and key factors that impact reinsurance structuring and pricing.

Description: Several presentations that contain analyses on the SOA’s Individual Life Experience Committee’s 2003 to 2013 Individual Life Mortality Experience Data are available below. The final 2003 to 2013 Individual Life Mortality Experience Report and data will be published later this year.

Description: This research report discusses simplified issue underwriting in life insurance. It examines recent developments, characteristics, challenges, current practices, assumptions and data elements.

Description: This report provides various summaries of the above listed data and provides observations from these summaries, with a goal to help actuaries understand the emerging trends in mortality due to COVID-19.